<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1542</article-id><article-id pub-id-type="doi">10.15690/vramn1542</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RHEUMATOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ РЕВМАТОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Value of Trabecular Bone Score in Patients with Rheumatic Diseases</article-title><trans-title-group xml:lang="ru"><trans-title>Значение трабекулярного костного индекса у больных ревматическими заболеваниями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6834-2651</contrib-id><name-alternatives><name xml:lang="en"><surname>Kolpakov</surname><given-names>Konstantin I.</given-names></name><name xml:lang="ru"><surname>Колпаков</surname><given-names>Константин Игоревич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>elmad95@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4890-0847</contrib-id><contrib-id contrib-id-type="spin">5494-7355</contrib-id><name-alternatives><name xml:lang="en"><surname>Korolev</surname><given-names>Maxim A.</given-names></name><name xml:lang="ru"><surname>Королев</surname><given-names>Максим Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor</p></bio><bio xml:lang="ru"><p>к.м.н, доцент</p></bio><email>kormax@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6330-1044</contrib-id><name-alternatives><name xml:lang="en"><surname>Ubshaeva</surname><given-names>Yuliya B.</given-names></name><name xml:lang="ru"><surname>Убшаева</surname><given-names>Юлия Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>leobina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт клинической и экспериментальной лимфологии – филиал Института цитологии и генетики Сибирского отделения Российской академии наук</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-10-22" publication-format="electronic"><day>22</day><month>10</month><year>2021</year></pub-date><volume>76</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>402</fpage><lpage>411</lpage><history><date date-type="received" iso-8601-date="2021-04-09"><day>09</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-31"><day>31</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Издательство "Педиатръ"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-10-22"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1542">https://vestnikramn.spr-journal.ru/jour/article/view/1542</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>Trabecular bone score obtained by lumbar spine Dual-energy X-ray Absorptiometry is a novel and insufficiently explored instrument of accessing trabecular bone quality. One of its promising applications is early diagnostics of osteoporosis (OP) before fragility fractures appear. Meanwhile most of systemic inflammatory rheumatic diseases affect bone tissue either directly and indirectly by glucocorticoids consumption. Both factors potentiate OP development and can influence the trabecular bone score. </p> <p><bold>Aims</bold> — to evaluate the possibilities of trabecular bone score using in rheumatology.<bold> </bold></p> <p><bold>Materials and Methods.</bold> Data analysis of domestic and foreign scientific publications.<bold> </bold></p> <p><bold>Results and Discussion.</bold> Authors of analyzed publications note stable association of low trabecular bone score with vertebral fractures, its correlation with local inflammatory markers in lumbar spine and ankylosing spondylitis structural progression. In most studies trabecular bone score do not have association with systemic inflammatory activity and treatment.<bold> </bold></p> <p><bold>Conclusion.</bold> Trabecular bone score is effective in OP diagnostics in rheumatic patients, evaluation of local inflammatory activity in the lumbar spine and structural progression of ankylosing spondylitis.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Трабекулярный костный индекс, получаемый при двухэнергетической рентгеновской абсорбциометрии поясничного отдела позвоночника в прямой проекции, является относительно новым и малоизученным инструментом оценки строения трабекулярной костной ткани. Одно из перспективных возможностей его практического применения — ранняя диагностика остеопороза (ОП) до развития патологических переломов. В то же время многие ревматические системные воспалительные заболевания прямо поражают костно-мышечную систему и контролируются глюкокортикоидами. Оба фактора потенцируют развитие ОП и могут вызывать изменение трабекулярного костного индекса.<bold> </bold></p> <p><bold>Цель работы</bold> — оценить возможности применения трабекулярного костного индекса у больных ревматическими заболеваниями. </p> <p><bold>Материалы</bold><bold> </bold><bold>и</bold><bold> </bold><bold>методы.</bold> Анализ данных отечественной и зарубежной литературы, научных публикаций, электронных ресурсов.<bold> </bold></p> <p><bold>Результаты</bold><bold> </bold><bold>и</bold><bold> </bold><bold>обсуждение.</bold> Авторы научных публикаций отмечают стабильную ассоциацию низких значений трабекулярного костного индекса у ревматологических пациентов с компрессионными переломами позвонков, его корреляцию с маркерами локального воспаления в позвоночнике и структурного прогрессирования анкилозирующего спондилита. В большинстве исследований трабекулярный костный индекс не показал четкой взаимосвязи с системной воспалительной активностью ревматических заболеваний и принимаемой терапией.<bold> </bold></p> <p><bold>Выводы. </bold>Трабекулярный костный индекс эффективен в диагностике остеопороза у пациентов с ревматическими заболеваниями, оценке активности локальной воспалительной реакции и структурного прогрессирования при анкилозирующем спондилите.</p></trans-abstract><kwd-group xml:lang="en"><kwd>trabecular bone</kwd><kwd>dual-energy X-ray absorptiometry</kwd><kwd>osteoporosis</kwd><kwd>rheumatology</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>трабекулярный костный индекс</kwd><kwd>денситометрия</kwd><kwd>остеопороз</kwd><kwd>ревматология</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Мельниченко Г.А., Белая Ж.Е., Лесняк О.М., и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза // Проблемы эндокринологии. — 2017. — Т. 63. — № 6. — С. 392–426. [Mel’nichenko GA, Belaya ZhE, Rozhinskaya LYa, et al. Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis. Problems of Endocrinology. 2017;63(6):392–426. (In Russ.)] doi: https://doi.org/10.14341/probl2017636392-426</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kanis JA, Johansson H, Harvey NC, McCloskey EV. A Brief History of FRAX. Arch Osteoporos. 2018;13(1):118–128. doi: https://doi.org/10.1007/s11657-018-0510-0</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Миронов С.П., Родионова С.С., Торгашин А.Н. Проект рекомендаций. Фармакотерапия для профилактики повторных переломов у больных остеопорозом после хирургического лечения патологического перелома проксимального отдела бедренной кости // Вестник травматологии и ортопедии им. Н.Н. Пирогова. — 2017. — Т. 24. — № 1. — С. 47–57. [Mironov SP, Rodionova SS, Torgashin AN. Draft Recommendations. Pharmacotherapy for the Prevention of Repeated Fractures in Patients with Osteoporosis after Surgical Treatment of Pathologic Proximal Femur Fracture. N.N. Priorov Journal of Traumatology and Orthopedics. 2017;24(1):47–57. (In Russ.)] doi: https://doi.org/10.17816/vto201724147-57</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Kanis JA, Johnell O, Oden A, et al. FRAX and the Assessment of Fracture Probability in Men and Women from the UK. Osteoporos Int. 2008;19(4):385–397. doi: https://doi.org/10.1007/s00198-007-0543-5</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kanis JA, Harvey NC, Johansson H, et al. FRAX Update. J Clin Densitom. 2017;20(3):360–367. doi: https://doi.org/10.1016/j.jocd.2017.06.022</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Compston J. FRAX — Where Are We Now? Maturitas. 2015;82(3):284–287. doi: https://doi.org/10.1016/j.maturitas.2015.07.024</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kanis JA, Harvey NC, Cooper C, et al. A Systematic Review of Intervention Thresholds Based on FRAX: A Report Prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):25–125. doi: https://doi.org/10.1007/s11657-016-0278-z</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Leslie WD, Johansson H, McCloskey EV, et al. Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry. J Bone Miner Res. 2018;33(11):1923–1930. doi: https://doi.org/10.1002/jbmr.3538</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Грачева Т.В., Лесняк О.М. Трабекулярный костный индекс при сахарном диабете // Остеопороз и остеопатии. — 2016. — Т. 19. — № 2. — С. 42. [Gracheva TV, Lesnyak OM. Trabekulyarnyi kostnyi indeks pri sakharnom diabete. Osteoporos i osteopatii = Osteoporosis and Bone Diseases. 2016;19(2):42. (In Russ.)]</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Broy SB, Tanner SB. Official Positions for FRAX Clinical Regarding Rheumatoid Arthritis From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX. J Clin Densitom. 2011;14(3):184–189. doi: https://doi.org/10.1016/j.jocd.2011.05.012</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jain RK, Vokes T. Dual-energy X-ray Absorptiometry. J Clin Densitom. 2017;20(3):291–303. doi: https://doi.org/10.1016/j.jocd.2017.06.014</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kolta S, Briot K, Fechtenbaum J, et al. TBS Result Is Not Affected by Lumbar Spine Osteoarthritis. Osteoporos Int. 2014;25(6):1759–1764. doi: https://doi.org/10.1007/s00198-014-2685-6</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Muschitz C, Kocijan R, Haschka J, et al. TBS Reflects Trabecular Microarchitecture in Premenopausal Women and Men with Idiopathic Osteoporosis and Low-Traumatic Fractures. Bone. 2015;79:259–266. doi: https://doi.org/10.1016/j.bone.2015.06.007</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Robert JW, Roberts CC, Bencardino JT, et al. ACR Appropriateness Criteria of Osteoporosis and Bone Mineral Density. J Am Coll Radiol. 2017;14(5S):189–202. doi: https://doi.org/10.1016/j.jacr.2017.02.018</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bonani M, Frey D, Graf N, Wuthrich RP. Effect of Denosumab on Trabecular Bone Score in De Novo Kidney Transplant Recipients. Nephrol Dial Transplant. 2019;34(10):1773–1780. doi: https://doi.org/10.1093/ndt/gfy411</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Saag KG, Agnusdei D, Hans D, et al. Trabecular Bone Score in Patients with Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated with Alendronate or Teriparatide. Arthritis Rheumatol. 2016;68(9):2122–2128. doi: https://doi.org/10.1056/NEJMoa071408</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Shevroja E, Lamy O, Kohlmeier L, et al. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice. J Clin Densitom. 2017;20(3):334–345. doi: https://doi.org/10.1016/j.jocd.2017.06.019</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of Fracture Risk in Postmenopausal White Women with Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002;17(12):2222–2230. doi: https://doi.org/10.1359/jbmr.2002.17.12.2222</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pasco JA, Seeman E, Henry MJ, et al. The Population Burden of Fractures Originates in Women with Osteopenia, Not Osteoporosis. Osteoporos Int. 2006;17(9):1404–1409. doi: https://doi.org/10.1007/s00198-006-0135-9</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Silva BC, Broy SB, Boutroy S, et al. Fracture Risk Prediction by Non-BMD DXA Measures: The 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J Clin Densitom. 2015;18(3):309–330. doi: https://doi.org/10.1016/j.jocd.2015.06.008</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Orstavik RE, Haugeberg G, Mowinckel P. Vertebral Deformities in Rheumatoid Arthritis: A Comparison with Population-Based Controls. Arch Intern Med. 2004;164(4):420–425. doi: https://doi.org/10.1001/archinte.164.4.420</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bultink IEM, Lems WF. Lupus and fractures. Curr Opin Rheumatol. 2016;28(4):426–432. doi: https://doi.org/10.1097/BOR.0000000000000290</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Siris ES, Chen Y, Abbott TA, et al. Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures. Arch Intern Med. 2004;164(10):1108–1112. doi: https://doi.org/10.1001/archinte.164.10.1108</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Krohn K, Schwartz EN, Chung Y, Lewiecki EM. Dual-Energy X-Ray Absorptiometry Monitoring with Trabecular Bone Score: 2019 ISCD Official Positions. J Clin Densitom. 2019;22(4):501–505. doi: https://doi.org/10.1016/j.jocd.2019.07.006</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>McCloskey EV, Oden A, Harvey NC, et al. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res. 2016;31(5):940–948. doi: https://doi.org/10.1002/jbmr.2734</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Martineau P, Leslie WD. Trabecular Bone Score (TBS): Method and Applications. Bone. 2017;104:66–72. doi: https://doi.org/10.1016/j.bone.2017.01.035</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Поворознюк В.В., Дзерович Н.И. Качество трабекулярной костной ткани у женщин в зависимости от длительности постменопаузального периода // Боль. Суставы. Позвоночник. — 2012. — № 2. — С. 86–88. [Povoroznyuk VV, Dzerovich NI. Kachestvo trabekulyarnoi kostnoi tkani u zhenshchin v zavisimosti ot dlitel’nosti postmenopauzal’nogo perioda. Pain. Joints. Spine. 2012;(2):86–88. (In Russ.)]</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Поворознюк В.В., Дель Рио Л., Ди Грегорио С., и др. Отличается ли показатель качества трабекулярной костной ткани у практически здоровых мужчин и женщин европеоидной расы? Создание нормативной базы данных показателя качества трабекулярной костной ткани (TBS) для мужчин // Боль. Суставы. Позвоночник. — 2014. — № 3. — С. 20–23. [Povoroznyuk VV, Del Rio L, Di Gregorio S, et al. Is TBS different in healthy european caucasian men and women? Creation of normative spine TBS data for men. Pain. Joints. Spine. 2014;(3):20–23. (In Russ.)]</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Поворознюк В.В., Мусиенко А.С., Дзерович Н.И. Минеральная плотность и качество костной ткани, 10-летний риск остеопоретических переломов у украинских мужчин различного возраста // Боль. Суставы. Позвоночник. — 2013. — № 3. — С. 52–55. [Povoroznyuk VV, Musienko AS, Dzerovich NI. Mineral’naya plotnost’ i kachestvo kostnoi tkani, 10-letnii risk osteoporeticheskikh perelomov u ukrainskikh muzhchin razlichnogo vozrasta. Pain. Joints. Spine. 2013;(3):52–55. (In Russ.)]</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Баранова И.А., Ершова О.Б., Анаев Э.Х., и др. Анализ оказания консультативной медицинской помощи пациентам с глюкокортикоидным остеопорозом или риском его развития по данным анкетирования пациентов (исследование ГЛЮКОСТ) // Терапевтический архив. — 2015. — Т. 87. — № 5. — С. 58–64. [Baranova IA, Ershova OB, Anaev EKh, et al. Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study). Terapevticheskiy arkhiv = Therapeutic archive. 2015;87(5):58–64. (In Russ.)] doi: https://doi.org/10.17116/terarkh201587558-64</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Choi YJ, Chung Y, Suh C, et al. Trabecular Bone Score as a Supplementary Tool for the Discrimination of Osteoporotic Fractures in Postmenopausal Women with Rheumatoid Arthritis. Medicine (Baltimore). 2017;96(45):e8861. doi: https://doi.org/10.1097/MD.0000000000008661</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Jung J, Han SH, Hong YS, et al. Inflammation on Spinal Magnetic Resonance Imaging Is Associated with Poor Bone Quality in Patients with Ankylosing Spondylitis. Mod Rheumatol. 2019;29(5):829–835. doi: https://doi.org/10.1080/14397595.2018.1510877</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Kang KY, Goo HY, Park S, Hong YS. Trabecular Bone Score as an Assessment Tool to Identify the Risk of Osteoporosis in Axial Spondyloarthritis: A Case-Control Study. Rheumatology (Oxford). 2018;57(3):462–469. doi: https://doi.org/10.1093/rheumatology/kex377</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Boussoualim K, Amouzougan A, Pallot-Prades B, et al. Evaluation of Bone Quality with Trabecular Bone Score in Active Spondyloarthritis. Joint Bone Spine. 2018;85(6):727–731. doi: https://doi.org/10.1016/j.jbspin.2018.02.006</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Lai E, Huang W, Chen H, et al. Degraded Microarchitecture by Low Trabecular Bone Score Is Associated with Prevalent Vertebral Fractures in Patients with Systemic Lupus Erythematosus. Arch Osteoporos. 2020;15(1):54. doi: https://doi.org/10.1007/s11657-020-00726-3</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Breban S, Briot K, Kolta S, et al. Identification of Rheumatoid Arthritis Patients with Vertebral Fractures Using Bone Mineral Density and Trabecular Bone Score. J Clin Densitom. 2012;15(3):260–266. doi: https://doi.org/10.1016/j.jocd.2012.01.007</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kang KY, Ju JH, Park S, Hong YS. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study. J Rheumatol. 2020;47(9):1330–1337. doi: https://doi.org/10.3899/jrheum.190749</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Kang KY, Chung MK, Kim HN, et al. Severity of Sacroiliitis and Erythrocyte Sedimentation Rate Are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis. J Rheumatol. 2018;45(3):349–356. doi: https://doi.org/10.3899/jrheum.170079</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Koumakis E, Avouac J, Winzenrieth R, et al. Trabecular Bone Score in Female Patients with Systemic Sclerosis: Comparison with Rheumatoid Arthritis and Influence of Glucocorticoid Exposure. J Rheumatol. 2015;42(2):228–235. doi: https://doi.org/10.3899/jrheum.140752</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Caparbo VF, Furlam P, Saad CGS, et al. Assessing Bone Impairment in Ankylosing Spondylitis (AS) Using the Trabecular Bone Score (TBS) and High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT). Bone. 2019;122:8–13. doi: https://doi.org/10.1016/j.bone.2019.01.024</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Kim D, Cho S, Kim JY, et al. Association Between Trabecular Bone Score and Risk Factors for Fractures in Korean Female Patients with Rheumatoid Arthritis. Mod Rheumatol. 2016;26(4):540–545. doi: https://doi.org/10.3109/14397595.2015.1101212</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Kim J, Chung MK, Lee J, et al. Low Bone Mineral Density of Vertebral Lateral Projections Can Predict Spinal Radiographic Damage in Patients with Ankylosing Spondylitis. Clin Rheumatol. 2019;38(12):3567–3574. doi: https://doi.org/10.1007/s10067-019-04743-7</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Ruaro B, Casabella A, Paolino S, et al. Dickkopf-1 (Dkk-1) Serum Levels in Systemic Sclerosis and Rheumatoid Arthritis Patients: Correlation with the Trabecular Bone Score (TBS). Clin Rheumatol. 2018;37(11):3057–3062. doi: https://doi.org/10.1007/s10067-018-4322-9</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Ruaro B, Casabella A, Paolino S, et al. Correlation Between Bone Quality and Microvascular Damage in Systemic Sclerosis Patients. Rheumatology (Oxford). 2018;57(9):1548–1554. doi: https://doi.org/10.1093/rheumatology/key130</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Wildberger L, Boyadzhieva V, Hans D, et al. Impact of Lumbar Syndesmophyte on Bone Health as Assessed by Bone Density (BMD) and Bone Texture (TBS) in Men with Axial Spondyloarthritis. Joint Bone Spine. 2017;84(4):463–466. doi: https://doi.org/10.1016/j.jbspin.2016.05.015</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kang KY, Jung J, Lee SK, et al. Trabecular Bone Score Value Is Associated with New Bone Formation Independently of Fat Metaplasia on Spinal Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis. Scand J Rheumatol. 2020;49(4):292–300. doi: https://doi.org/10.1080/03009742.2019.1704053</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Killinger Z, Gajdarova L, Kuzma M, et al. Biologic Treatment in Comparison to Methotrexate Has Positive Effect on Trabecular Bone Score in Rheumatoid Arthritis Patients: 1-year Follow-Up. Acta Clin Belg. 2019;74(2):121–125. doi: https://doi.org/10.1080/17843286.2018.1512189</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Shimizu T, Choi HJ, Heilmeier U, et al. Assessment of 3-month Changes in Bone Microstructure under anti-TNFα Therapy in Patients with Rheumatoid Arthritis Using High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT). Arthritis Res Ther. 2017;19(1):222. doi: https://doi.org/10.1186/s13075-017-1430-x</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Toussirot É, Mourot L, Dehecq B, et al. Paradoxical Elevation of Serum TRACP5b Levels Despite Increase in Lumbar Spine Bone Mineral Density During anti-TNFα Therapy in Patients with Inflammatory Rheumatic Disease: A 2-year Prospective Assessment of Bone Mass, Bone Metabolism, and the Trabecular Bone Score. Eur J Rheumatol. 2017;4(3):189–193. doi: https://doi.org/10.5152/eurjrheum.2017.17006</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Che H, Breuil V, Cortet B, et al. Vertebral Fractures Cascade: Potential Causes and Risk Factors. Osteoporos Int. 2019;30(3):555–563. doi: https://doi.org/10.1007/s00198-018-4793-1</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Mundy GR. Osteoporosis and Inflammation. Nutr Rev. 2007;65(12):147–151. doi: https://doi.org/10.1111/j.1753-4887.2007.tb00353.x</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Hardy RS, Zhou H, Seibel MJ, Cooper MS. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy. Endocr Rev. 2018;39(5):519–548. doi: https://doi.org/10.1210/er.2018-00097</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Hoff M, Bøyesen P, Haugeberg G, et al. High Disease Activity Is a Predictor of Cortical Hand Bone Loss in Post-Menopausal Patients with Established Rheumatoid Arthritis: A 5-year Multicentre Longitudinal Study. Rheumatology (Oxford). 2010;49(9):1676–1682. doi: https://doi.org/10.1093/rheumatology/keq125</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Buckley L, Guyatt G, Fink HA, et al. American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res (Hoboken). 2017;69(8):1095–1110. doi: https://doi.org/10.1002/art.40137</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S47–S58. doi: https://doi.org/10.1002/acr.20575</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Chen C, Chen H, Liao H, et al. The Clinical Usefulness of ESR, CRP, and Disease Duration in Ankylosing Spondylitis: The Product of These Acute-Phase Reactants and Disease Duration Is Associated with Patient’s Poor Physical Mobility. Rheumatol Int. 2015;35(7):1263–1267. doi: https://doi.org/10.1007/s00296-015-3214-4</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Dufour R, Winzenrieth R, Heraud A, et al. Generation and Validation of a Normative, Age-Specific Reference Curve for Lumbar Spine Trabecular Bone Score (TBS) in French Women. Osteoporos Int. 2013;24(11):2837–2846. doi: https://doi.org/10.1007/s00198-013-2384-8</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Maksymowych WP, Morency N, Conner-Spady B, Lambert RG. Suppression of Inflammation and Effects on New Bone Formation in Ankylosing Spondylitis: Evidence for a Window of Opportunity in Disease Modification. Ann Rheum Dis. 2013;72(1):23–28. doi: https://doi.org/10.1136/annrheumdis-2011-200859</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Heijde D, Machado P, Braun J, et al. MRI Inflammation at the Vertebral Unit Only Marginally Predicts New Syndesmophyte Formation: A Multilevel Analysis in Patients with Ankylosing Spondylitis. Ann Rheum Dis. 2012;71(3):369–373. doi: https://doi.org/10.1136/annrheumdis-2011-200208</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. Inflammatory Lesions of the Spine on Magnetic Resonance Imaging Predict the Development of New Syndesmophytes in Ankylosing Spondylitis Evidence of a Relationship Between Inflammation and New Bone Formation. Arthritis Rheum. 2009;60(1):93–102. doi: https://doi.org/10.1002/art.24132</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Baraliakos X, Heldmann F, Callhoff J, et al. Which Spinal Lesions Are Associated with New Bone Formation in Patients with Ankylosing Spondylitis Treated with anti-TNF Agents? A Long-Term Observational Study Using MRI and Conventional Radiography. Ann Rheum Dis. 2014;73(10):1819–1825. doi: https://doi.org/10.1136/annrheumdis-2013-203425</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Гребенникова Т.А., Белая Ж.Е., Мельниченко Г.А. Возможности применения терипаратида для лечения тяжелого остеопороза вследствие сахарного диабета на примере клинического случая. — Сахарный Диабет — Пандемия XXI (сборник тезисов). — М.: УП ПРИНТ; 2018. — С. 454. [Grebennikova TA, Belaya ZhE, Mel’nichenko GA. Vozmozhnosti primeneniya teriparatida dlya lecheniya tyazhelogo osteoporoza vsledstvie sakharnogo diabeta na primere klinicheskogo sluchaya. In: Diabetes mellitus — XXIth century pandemia (Conference Proceedings). Moscow: UP PRINT; 2018. Р. 454. (In Russ.)]</mixed-citation></ref></ref-list></back></article>
